Partnering With Oxidium
At Oxidium Technologies, we believe innovation thrives through collaboration. Our partnership model empowers your brand to deliver advanced disinfection solutions without the burden of internal R&D or regulatory complexity. By combining your market expertise with our decades of chemical innovation, we create a foundation for growth—helping you launch differentiated products faster, with confidence and control.
Benefits of Partnering With Us
Chemical manufacturers face years of regulatory navigation and significant up-front investment when developing disinfectants. Oxidium Technologies eliminates these barriers. We provide established EPA-registered formulations based on proven Aseptrol technology—a chlorine dioxide chemistry developed over decades and developed and commercialized by BASF. The unique formulation allows for rapid ClO₂ generation in a small form-factor that’s stable for years until activated. You maintain brand ownership and market control; we handle technical and regulatory complexity.
This model has enabled established biosafety companies to build market-leading disinfection brands without additional in-house R&D investment. Regardless of the industry or application, Aseptrol allows your team to take advantage of decades of experience and create pure chlorine dioxide, virtually anywhere, in minutes.
Oxidium Technologies engineers proven chlorine dioxide chemistries that enable partners to deploy odor neutralization, sanitization, disinfection, or water treatment anywhere it’s needed—eliminating the technical, regulatory, and logistical barriers that make top-tier disinfection inaccessible.
About Aseptrol®
Aseptrol represents a family of chlorine dioxide-based disinfectants engineered for premium pathogen control in diverse applications. Acquired from BASF in 2026, Aseptrol® is now part of Oxidium Technologies’ portfolio—bringing proven chemistry to the industries that need it most.